MA PPO
  
MPNewsFlashTopicPub
  
  
MPPurposePub
  
  
6/15/2021
Notification of Upcoming Changes to Pharmacologic Nuclear Stress Testing in response to COVID-19
0
The purpose of this NewsFlash is to provide advance notice that medical necessity reviews will resume for new prior authorization requests on or after July 15, 2021 regarding the use of pharmacologic stress testing with nuclear imaging in lieu of exercise stress testing​. 
Notification of Upcoming Changes to Pharmacologic Nuclear Stress Testing in response to COVID-1912db6f3c-0bd0-4320-b0d1-2142499df5a3
4/16/2021
Pharmaceutical Treatments of COVID-19 for Independence Medicare Advantage Members (Updated May 4, 2021)
0.1

The purpose of this document is to Communicate the Company's coverage position for Pharmaceutical Treatment of COVID-19 for the Company's Medicare Advantage products. 

Pharmaceutical Treatments of COVID-19 for Independence Medicare Advantage Members (Updated May 4, 2021)5843cdc3-5769-41fc-b391-1b607c4dbe1d